BB

Bixapathi Balguri

Active Director Director DIN 08678386
DIN 08678386 First appointment Jan 2020 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Bixapathi Balguri

Data last updated:

Bixapathi Balguri is a Director at Spanish Pharmaceuticals Private Limited (since 2020). The company operates in Trading.

DIN 08678386
Primary Designation Director
Industry Trading
First Appointment 24 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20202020Active

Board colleagues of Bixapathi Balguri

NameDINCompanyDesignation
Gajjela Vennela08678387Spanish Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Spanish Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bixapathi Balguri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bixapathi Balguri

Bixapathi Balguri currently holds 1 directorship: Spanish Pharmaceuticals Private Limited (Director, since 24 Jan 2020).

Bixapathi Balguri was first appointed on 24 Jan 2020 as Director at Spanish Pharmaceuticals Private Limited.

The current boards of Bixapathi Balguri's companies include Gajjela Vennela (Spanish Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available